Principal Financial Group Inc. Buys 34,266 Shares of Pediatrix Medical Group, Inc. (NYSE:MD)

Principal Financial Group Inc. boosted its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 6.2% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 586,190 shares of the company's stock after buying an additional 34,266 shares during the quarter. Principal Financial Group Inc. owned 0.68% of Pediatrix Medical Group worth $8,494,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. XTX Topco Ltd acquired a new position in shares of Pediatrix Medical Group in the 4th quarter valued at $169,000. GAMMA Investing LLC grew its stake in Pediatrix Medical Group by 219.5% in the 1st quarter. GAMMA Investing LLC now owns 2,569 shares of the company's stock valued at $37,000 after acquiring an additional 1,765 shares during the last quarter. SG Americas Securities LLC grew its stake in Pediatrix Medical Group by 194.0% in the 1st quarter. SG Americas Securities LLC now owns 38,405 shares of the company's stock valued at $556,000 after acquiring an additional 25,343 shares during the last quarter. Deutsche Bank AG lifted its holdings in Pediatrix Medical Group by 53.1% in the 4th quarter. Deutsche Bank AG now owns 74,023 shares of the company's stock valued at $971,000 after purchasing an additional 25,663 shares in the last quarter. Finally, California State Teachers Retirement System lifted its holdings in Pediatrix Medical Group by 0.9% in the 4th quarter. California State Teachers Retirement System now owns 80,327 shares of the company's stock valued at $1,054,000 after purchasing an additional 752 shares in the last quarter. Hedge funds and other institutional investors own 97.71% of the company's stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the stock. Truist Financial dropped their price objective on shares of Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating for the company in a research note on Friday, April 11th. UBS Group dropped their target price on shares of Pediatrix Medical Group from $18.50 to $16.00 and set a "neutral" rating for the company in a research report on Monday, May 12th. Finally, Macquarie increased their target price on shares of Pediatrix Medical Group from $19.00 to $20.00 and gave the stock an "outperform" rating in a research report on Thursday, May 8th. Four investment analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. According to MarketBeat.com, Pediatrix Medical Group presently has an average rating of "Hold" and an average target price of $16.67.

Pediatrix Medical Group Trading Down 2.0%

Shares of NYSE:MD traded down $0.25 during midday trading on Friday, reaching $12.59. The company had a trading volume of 175,210 shares, compared to its average volume of 717,484. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.81 and a current ratio of 1.81. Pediatrix Medical Group, Inc. has a 1-year low of $7.40 and a 1-year high of $17.67. The firm has a market cap of $1.08 billion, a price-to-earnings ratio of -12.45, a price-to-earnings-growth ratio of 0.86 and a beta of 1.25. The company has a fifty day simple moving average of $13.87 and a two-hundred day simple moving average of $13.87.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last released its quarterly earnings results on Tuesday, May 6th. The company reported $0.33 earnings per share for the quarter, beating analysts' consensus estimates of $0.25 by $0.08. Pediatrix Medical Group had a positive return on equity of 17.43% and a negative net margin of 4.17%. The business had revenue of $458.36 million during the quarter, compared to analyst estimates of $451.44 million. During the same quarter last year, the company posted $0.20 EPS. Pediatrix Medical Group's revenue for the quarter was down 7.4% on a year-over-year basis. Research analysts predict that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current year.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.